annual FCF:
$10.10B-$56.38M(-0.55%)Summary
- As of today (August 22, 2025), NVO annual free cash flow is $10.10 billion, with the most recent change of -$56.38 million (-0.55%) on December 31, 2024.
- During the last 3 years, NVO annual FCF has risen by +$2.53 billion (+33.48%).
- NVO annual FCF is now -0.55% below its all-time high of $10.16 billion, reached on December 31, 2023.
Performance
NVO Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$761.64M-$3.51B(-82.15%)Summary
- As of today (August 22, 2025), NVO quarterly free cash flow is $761.64 million, with the most recent change of -$3.51 billion (-82.15%) on June 1, 2025.
- Over the past year, NVO quarterly FCF has dropped by -$4.64 billion (-85.89%).
- NVO quarterly FCF is now -85.89% below its all-time high of $5.40 billion, reached on June 30, 2024.
Performance
NVO quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$8.96B-$4.64B(-34.09%)Summary
- As of today (August 22, 2025), NVO TTM free cash flow is $8.96 billion, with the most recent change of -$4.64 billion (-34.09%) on June 1, 2025.
- Over the past year, NVO TTM FCF has dropped by -$610.64 million (-6.38%).
- NVO TTM FCF is now -34.09% below its all-time high of $13.60 billion, reached on March 31, 2025.
Performance
NVO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
NVO Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.6% | -85.9% | -6.4% |
| 3 y3 years | +33.5% | -75.1% | +4.9% |
| 5 y5 years | +89.5% | -77.5% | +27.3% |
NVO Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.6% | +33.5% | -85.9% | +176.3% | -34.1% | +22.3% |
| 5 y | 5-year | -0.6% | +121.0% | -85.9% | +141.4% | -34.1% | +96.1% |
| alltime | all time | -0.6% | +9827.5% | -85.9% | +141.4% | -34.1% | +8379.9% |
NVO Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $761.64M(-82.2%) | $8.96B(-34.1%) |
| Mar 2025 | - | $4.27B(-734.8%) | $13.60B(+34.6%) |
| Dec 2024 | $10.10B(-0.6%) | -$672.28M(-114.6%) | $10.10B(+3.3%) |
| Sep 2024 | - | $4.60B(-14.7%) | $9.78B(+2.1%) |
| Jun 2024 | - | $5.40B(+598.9%) | $9.57B(+30.7%) |
| Mar 2024 | - | $772.24M(-177.3%) | $7.33B(-27.9%) |
| Dec 2023 | $10.16B(+12.1%) | -$998.46M(-122.7%) | $10.16B(-8.8%) |
| Sep 2023 | - | $4.40B(+39.7%) | $11.14B(+17.6%) |
| Jun 2023 | - | $3.15B(-12.6%) | $9.47B(+1.0%) |
| Mar 2023 | - | $3.61B(<-9900.0%) | $9.38B(+3.5%) |
| Dec 2022 | $9.06B(+19.7%) | -$17.49M(-100.6%) | $9.06B(+11.6%) |
| Sep 2022 | - | $2.74B(-10.4%) | $8.12B(-5.0%) |
| Jun 2022 | - | $3.05B(-7.1%) | $8.54B(-7.9%) |
| Mar 2022 | - | $3.29B(-442.1%) | $9.28B(+22.6%) |
| Dec 2021 | $7.57B(+65.6%) | -$961.12M(-130.4%) | $7.57B(+13.2%) |
| Sep 2021 | - | $3.16B(-16.6%) | $6.69B(+25.3%) |
| Jun 2021 | - | $3.79B(+139.6%) | $5.34B(+8.3%) |
| Mar 2021 | - | $1.58B(-185.8%) | $4.93B(+7.8%) |
| Dec 2020 | $4.57B(-14.3%) | -$1.84B(-201.8%) | $4.57B(-31.9%) |
| Sep 2020 | - | $1.81B(-46.4%) | $6.72B(-4.6%) |
| Jun 2020 | - | $3.38B(+176.2%) | $7.04B(+27.8%) |
| Mar 2020 | - | $1.22B(+302.8%) | $5.51B(+3.4%) |
| Dec 2019 | $5.33B(+4.5%) | $303.77M(-85.8%) | $5.33B(-3.4%) |
| Sep 2019 | - | $2.14B(+15.5%) | $5.52B(+16.6%) |
| Jun 2019 | - | $1.85B(+77.1%) | $4.73B(-5.5%) |
| Mar 2019 | - | $1.04B(+112.3%) | $5.01B(-1.7%) |
| Dec 2018 | $5.10B(+3.4%) | $491.96M(-63.5%) | $5.10B(-0.3%) |
| Sep 2018 | - | $1.35B(-36.6%) | $5.12B(-6.2%) |
| Jun 2018 | - | $2.13B(+87.7%) | $5.45B(+19.2%) |
| Mar 2018 | - | $1.13B(+122.3%) | $4.58B(-7.2%) |
| Dec 2017 | $4.94B(-17.1%) | $509.72M(-69.7%) | $4.94B(-12.6%) |
| Sep 2017 | - | $1.68B(+34.8%) | $5.64B(-3.2%) |
| Jun 2017 | - | $1.25B(-16.2%) | $5.83B(-10.3%) |
| Mar 2017 | - | $1.49B(+22.3%) | $6.51B(+9.3%) |
| Dec 2016 | $5.95B(+25.6%) | $1.22B(-34.9%) | $5.95B(+1.6%) |
| Sep 2016 | - | $1.87B(-2.5%) | $5.86B(+3.9%) |
| Jun 2016 | - | $1.92B(+104.4%) | $5.64B(+5.7%) |
| Mar 2016 | - | $939.73M(-16.4%) | $5.33B(+9.0%) |
| Dec 2015 | $4.74B(-3.8%) | $1.12B(-32.1%) | $4.89B(+4.0%) |
| Sep 2015 | - | $1.65B(+2.5%) | $4.71B(-6.9%) |
| Jun 2015 | - | $1.61B(+223.4%) | $5.05B(+6.0%) |
| Mar 2015 | - | $499.33M(-46.7%) | $4.77B(-2.1%) |
| Dec 2014 | $4.93B(+24.2%) | $937.11M(-53.2%) | $4.87B(+2.2%) |
| Sep 2014 | - | $2.00B(+50.6%) | $4.76B(+29.2%) |
| Jun 2014 | - | $1.33B(+121.5%) | $3.69B(+6.0%) |
| Mar 2014 | - | $600.03M(-27.8%) | $3.48B(-12.4%) |
| Dec 2013 | $3.97B(+23.7%) | $831.21M(-10.2%) | $3.97B(+24.0%) |
| Sep 2013 | - | $926.02M(-17.3%) | $3.20B(-7.2%) |
| Jun 2013 | - | $1.12B(+2.4%) | $3.45B(+8.5%) |
| Mar 2013 | - | $1.09B(+1614.8%) | $3.18B(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $3.21B(-4.7%) | $63.73M(-94.6%) | $3.21B(-11.8%) |
| Sep 2012 | - | $1.18B(+38.4%) | $3.64B(-3.7%) |
| Jun 2012 | - | $849.06M(-24.2%) | $3.78B(+3.1%) |
| Mar 2012 | - | $1.12B(+127.7%) | $3.66B(+8.7%) |
| Dec 2011 | $3.37B(+20.0%) | $491.90M(-62.6%) | $3.37B(-3.7%) |
| Sep 2011 | - | $1.32B(+79.0%) | $3.50B(+11.1%) |
| Jun 2011 | - | $734.64M(-11.1%) | $3.15B(+5.0%) |
| Mar 2011 | - | $825.98M(+33.1%) | $3.00B(+6.9%) |
| Dec 2010 | $2.81B(+21.5%) | $620.67M(-35.8%) | $2.81B(+4.7%) |
| Sep 2010 | - | $967.25M(+65.3%) | $2.68B(+6.7%) |
| Jun 2010 | - | $585.17M(-7.5%) | $2.51B(+8.8%) |
| Mar 2010 | - | $632.60M(+28.0%) | $2.31B(-0.0%) |
| Dec 2009 | $2.31B(+6.4%) | $494.20M(-38.2%) | $2.31B(+3.0%) |
| Sep 2009 | - | $799.16M(+108.6%) | $2.24B(+10.1%) |
| Jun 2009 | - | $383.05M(-39.5%) | $2.04B(-8.7%) |
| Mar 2009 | - | $633.64M(+48.5%) | $2.23B(+2.8%) |
| Dec 2008 | $2.17B(+30.8%) | $426.80M(-28.0%) | $2.17B(-7.8%) |
| Sep 2008 | - | $592.56M(+2.5%) | $2.36B(+2.8%) |
| Jun 2008 | - | $577.83M(+0.7%) | $2.29B(+21.6%) |
| Mar 2008 | - | $573.80M(-6.1%) | $1.88B(+12.1%) |
| Dec 2007 | $1.66B(+123.0%) | $610.96M(+15.7%) | $1.68B(+72.8%) |
| Sep 2007 | - | $528.18M(+208.5%) | $972.75M(+5.7%) |
| Jun 2007 | - | $171.23M(-53.8%) | $920.63M(-2.5%) |
| Mar 2007 | - | $370.47M(-481.4%) | $943.80M(+15.9%) |
| Dec 2006 | $743.95M(-1.9%) | -$97.14M(-120.4%) | $814.46M(-23.5%) |
| Sep 2006 | - | $476.06M(+144.9%) | $1.07B(+19.1%) |
| Jun 2006 | - | $194.39M(-19.4%) | $894.71M(-4.2%) |
| Mar 2006 | - | $241.14M(+56.9%) | $934.19M(+16.4%) |
| Dec 2005 | $758.23M(+9.7%) | $153.68M(-49.7%) | $802.24M(+1.3%) |
| Sep 2005 | - | $305.50M(+30.6%) | $791.62M(+5.2%) |
| Jun 2005 | - | $233.87M(+114.2%) | $752.25M(+0.8%) |
| Mar 2005 | - | $109.19M(-23.7%) | $746.58M(+0.5%) |
| Dec 2004 | $690.98M(+24.3%) | $143.07M(-46.2%) | $743.07M(+23.8%) |
| Sep 2004 | - | $266.13M(+16.6%) | $600.01M(+79.7%) |
| Jun 2004 | - | $228.20M(+115.9%) | $333.88M(+215.9%) |
| Mar 2004 | - | $105.68M | $105.68M |
| Dec 2003 | $555.90M(+374.1%) | - | - |
| Dec 2002 | $117.26M(+159.1%) | - | - |
| Dec 2001 | $45.26M(-87.3%) | - | - |
| Dec 2000 | $357.30M(+47.3%) | - | - |
| Dec 1999 | $242.57M(+21.5%) | - | - |
| Dec 1998 | $199.60M(+175.8%) | - | - |
| Dec 1997 | $72.36M(+490.9%) | - | - |
| Dec 1996 | $12.25M(-93.4%) | - | - |
| Dec 1995 | $184.45M(+170.7%) | - | - |
| Dec 1994 | $68.14M(-190.9%) | - | - |
| Dec 1993 | -$74.95M(-27.8%) | - | - |
| Dec 1992 | -$103.85M(+306.5%) | - | - |
| Dec 1991 | -$25.55M(-147.5%) | - | - |
| Dec 1990 | $53.82M(+164.9%) | - | - |
| Dec 1989 | $20.32M | - | - |
FAQ
- What is Novo Nordisk A/S annual free cash flow?
- What is the all time high annual FCF for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual FCF year-on-year change?
- What is Novo Nordisk A/S quarterly free cash flow?
- What is the all time high quarterly FCF for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly FCF year-on-year change?
- What is Novo Nordisk A/S TTM free cash flow?
- What is the all time high TTM FCF for Novo Nordisk A/S?
- What is Novo Nordisk A/S TTM FCF year-on-year change?
What is Novo Nordisk A/S annual free cash flow?
The current annual FCF of NVO is $10.10B
What is the all time high annual FCF for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual free cash flow is $10.16B
What is Novo Nordisk A/S annual FCF year-on-year change?
Over the past year, NVO annual free cash flow has changed by -$56.38M (-0.55%)
What is Novo Nordisk A/S quarterly free cash flow?
The current quarterly FCF of NVO is $761.64M
What is the all time high quarterly FCF for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly free cash flow is $5.40B
What is Novo Nordisk A/S quarterly FCF year-on-year change?
Over the past year, NVO quarterly free cash flow has changed by -$4.64B (-85.89%)
What is Novo Nordisk A/S TTM free cash flow?
The current TTM FCF of NVO is $8.96B
What is the all time high TTM FCF for Novo Nordisk A/S?
Novo Nordisk A/S all-time high TTM free cash flow is $13.60B
What is Novo Nordisk A/S TTM FCF year-on-year change?
Over the past year, NVO TTM free cash flow has changed by -$610.64M (-6.38%)